Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.
about
Galantamine for Alzheimer's disease and mild cognitive impairmentGalantamine for Alzheimer's diseaseQuetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trialBoosting visual cortex function and plasticity with acetylcholine to enhance visual perception.Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapyPersistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer diseaseMethods to improve the detection of mild cognitive impairmentMultimorbidity and weight loss in obese primary care patients: longitudinal study based on electronic healthcare records.Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial.Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.Adding memantine to rivastigmine therapy in patients with mild-to-moderate alzheimer's disease: results of a 12-week, open-label pilot study.Emerging links between type 2 diabetes and Alzheimer's diseaseNeuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic reviewComparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: a preliminary anti- Alzheimer's studyCognitive training in Alzheimer's disease: a meta-analysis of the literature.Safety and efficacy of rivastigmine in patients with Alzheimer's disease not responding adequately to donepezil: an open-label studyRivastigmine in the treatment of Alzheimer's disease: an update.Memantine: efficacy and safety in mild-to-severe Alzheimer's disease.Behavioral and psychological symptoms of dementia and their management.Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study.Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer's disease.Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
P2860
Q24244773-0F1A8674-A45B-4F54-A3C7-E4FB175678D7Q24246158-FF67FB70-D80C-4948-A4A8-CB2370FB3316Q24555726-18456329-745D-4E75-AF92-8BAF66C1E2D5Q26998400-94E9198F-6616-46D1-857F-E4C0B720B6F1Q30432684-91238CC2-E7B9-40A3-93FF-27CD04ABE842Q33867858-490D1002-3204-40C0-9C3C-04AAC40ABFAFQ33933152-527CB23B-6C73-4C58-B398-98429ED6C4FAQ35203985-CE09C62C-E238-4126-9A4B-52D607470E98Q35276747-89DAF7CF-671C-4E88-92E3-A9FA1C01DFC1Q35327053-C84DB33E-C7E4-4F9D-8B92-A30811C8AB64Q35574508-6DA01C27-F357-4000-B17D-D07B87C26689Q35691390-32F0638C-6B77-4810-9FD9-E229A41E34E0Q36227586-F0424C8B-E603-41E1-965D-6FF26C1526D8Q36247233-003CE203-A9F0-419F-BA88-26A84DE8AEA1Q36534246-721F0F19-C27C-4202-811C-2594DFDE5990Q36859507-A78DD741-6558-4841-8F14-58A1B9641ECFQ37017260-937D95F7-72F5-4874-BA57-AB690B5797C7Q37125743-21722D79-719A-484B-BA3D-56375D21FE0EQ37854476-FDCE4BED-B468-4E25-846F-6EC2947DF6F8Q38398560-882A263E-C796-4B69-B4D6-EC6A180B2BF2Q40428668-890D2F22-62C1-4D85-9B0F-E884FFB27B53Q49643940-C64D88EA-748A-4313-8B3B-F919E2897BE1Q51906755-AA4C055D-763C-42E1-A8FA-AA1ABE614779
P2860
Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.
@ast
Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.
@en
type
label
Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.
@ast
Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.
@en
prefLabel
Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.
@ast
Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.
@en
P1476
Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations.
@en
P2093
Jeffrey L Cummings
P304
P356
10.1176/APPI.AJGP.11.2.131
P577
2003-03-01T00:00:00Z